News

Led by Partner Pamela Duffy, the Exploratorium museum’s move to Piers 15 -17 on the San Francisco Embarcadero has been awarded a “Top Real Estate Development Deal” for 2011.
Click here to download the document

+ More

15 Coblentz partners have been recognized by Law and Politics as 2011 Northern California Super Lawyers. Super Lawyers selects attorneys using a rigorous, multiphase rating process. Peer nominations and evaluations are combined with third party research. Each candidate is evaluated on 12 indicators of peer recognition and professional achievement. Selections are made on an annual, state-by-state basis. The final published list represents no more than 5 percent of the lawyers in the state. Super Lawyers is a comprehensive and diverse listing of outstanding attorneys representing a wide range of practice areas, firm sizes and geographic locations.

Pamela Duffy was also named to the distinguished list of the Top 50 Women Lawyers, and as one of the Top 100 Lawyers in Northern California. She has been recognized since 2004 by Super Lawyers.

Click here to view the complete list of Coblentz lawyers who are named in the 2011 list.

+ More

Paul Tauber served as counsel to Open SystemC Initiative (OSCI) in negotiations to form a single organization with Accellera. The two industry organizations are focused on the creation and adoption of electronic design automation (EDA) and intellectual property (IP) standards, and recently signed a memorandum of understanding, beginning the process of combining the groups in order to create more comprehensive standards to benefit the worldwide electronic design community, and facilitate efficient collaboration among their members.

+ More

Howard Lasky, with assistance from Brandi Brown, represented Ascentia Wine Estates in the sale of Gary Farrell Winery and Buena Vista Carneros.

Click here for more information.

In Cedar Fair v. City of Santa Clara. (2011) 194 Cal.App.4th 1150, Coblentz, Patch, Duffy & Bass litigation attorneys Jonathan Bass and Charmaine Yu prevailed in a CEQA action challenging the proposed stadium for the San Francisco Forty Niners football team.

Click here to read the full update.

+ More

Howard Lasky and Eleanor Hicks represented JiWire Inc., a location-based mobile advertising company, in its $20 million Series C funding. This latest round brings JiWire's total venture funding to $45 million.

Paul Tauber served as lead counsel for Chronix Biomedical in solidifying an exclusive license agreement with Myriad Genetics to commercialize Chronix's early cancer detection technology. Chronix is extremely pleased with the closing of this significant deal, one that will ultimately progress Chronix's proprietary technology and tests.

Chronix Biomedical has pioneered a breakthrough approach to the diagnosis, monitoring and management of a broad range of cancers and other conditions through proprietary technology that measures and categorizes DNA sequences circulating in the blood that are associated with specific changes in disease and health status. Myriad Genetics, Inc., is a leading molecular diagnostic company dedicated to developing and marketing novel predictive, personalized and prognostic medicine products to assess a person's risk of developing disease and guide treatment decisions.

"We are pleased with the partnership of our technology with Myriad Genetics given their expertise in developing and commercializing molecular diagnostic products," said Dr. Howard Urnovitz, Chief Executive Officer of Chronix Biomedical. "The technology we have licensed from Chronix Biomedical has the potential to revolutionize the early detection of cancer through the analysis of unique DNA sequences in blood samples," said Mark Capone, President of Myriad Genetic Laboratories, Inc.

Under the terms of the agreement, Myriad has exclusive rights in North America, South America, and Europe to commercialize tests developed from the Chronix Biomedical technology for the early detection of breast, colon, and prostate cancer. In turn, Myriad will help validate these tests and will pay Chronix an undisclosed sum in upfront fees, milestone payments, and royalty payments upon the technical and commercial success of the products. The success of the development and commercialization of these early detection cancer tests could end up being a highly profitable investment for Myriad and a significant authentication for Chronix.

+ More

Here is the complete list of the winners and finalists and their categories recognized in the San Francisco Business Times 2010 Real Estate Deals of the Year Awards:

Winner of Office Lease/Sublease for San Francisco: Zynga.

Winner of Residential Market-Rate for San Francisco: One Hawthorne.

Winner for Rehab/Renovation: Presidio Landmark.

Finalist for Infrastructure/Public-Private: Exploratorium.

+ More

San Francisco Business Times selected Danna Kozerski as one of the “2011 Most Influential Women in Business” and honored Pamela Duffy as a “Forever Influential” inductee. The publication honors women leaders who are making a difference in their companies, their industries and their communities. 

Read the full article here.

+ More

The 2011 Finance Monthly Law Awards recognizes firms that have dedicated their resources to innovation, built on their depth of expertise and have performed outstandingly over the year. Finance Monthly sent a voting ballot to over 36,000 contacts resulting in this distinction for Coblentz's Business Practice.

+ More